Publications by authors named "David Jungck"

Claim this Profile
B
Biomarkers for Comorbidities Modulate the Activity of T-Cells in COPD.
Kaschin Jamal Jameel, Willem-Jakob Gallert, Sarah D Yanik, Susanne Panek, Juliane Kronsbein, David Jungck

Int J Mol Sci· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LABAs and p38MAPK Inhibitors Reverse the Corticosteroid-Insensitivity of IL-8 in Airway Smooth Muscle Cells of COPD.
Jürgen Knobloch, David Jungck, Juliane Kronsbein, Erich Stoelben, Kazuhiro Ito

J Clin Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The monocyte-dependent immune response to bacteria is suppressed in smoking-induced COPD.
Jürgen Knobloch, Susanne Panek, Sarah Derya Yanik, Kaschin Jamal Jameel, Zeynep Bendella, David Jungck

J Mol Med (Berl)· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superior anti-inflammatory effects of narrow-spectrum kinase inhibitors in airway smooth muscle cells from subjects with chronic obstructive pulmonary disease.
Jürgen Knobloch, David Jungck, Catherine Charron, Erich Stoelben, Kazuhiro Ito

J Allergy Clin Immunol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simvastatin requires activation in accessory cells to modulate T-cell responses in asthma and COPD.
Jürgen Knobloch, Yakup Yakin, Sandra Körber, Barbara Grensemann, Zeynep Bendella, David Jungck

Eur J Pharmacol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNFα-induced airway smooth muscle cell proliferation depends on endothelin receptor signaling, GM-CSF and IL-6.
Jürgen Knobloch, Sarah Derya Yanik, Sandra Körber, Erich Stoelben, David Jungck

Biochem Pharmacol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systemic defect in Toll-like receptor 4 signaling increases lipopolysaccharide-induced suppression of IL-2-dependent T-cell proliferation in COPD.
Jürgen Knobloch, Sarah-Jane Chikosi, Sarah Yanik, Jan Rupp, David Jungck

Am J Physiol Lung Cell Mol Physiol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelin receptor-antagonists suppress lipopolysaccharide-induced cytokine release from alveolar macrophages of non-smokers, smokers and COPD subjects.
Kathrin Gerlach, Stefanie Köhler-Bachmann, David Jungck, Sandra Körber, Sarah Yanik

Eur J Pharmacol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelin receptor B protects granulocyte macrophage colony-stimulating factor mRNA from degradation.
David Jungck, Jürgen Knobloch, Sandra Körber, Yingfeng Lin, Jürgen Konradi

J Pharmacol Exp Ther· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease.
Jürgen Knobloch, Chiara Wahl, Maria Feldmann, David Jungck, Justus Strauch

Basic Clin Pharmacol Toxicol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelin receptor antagonists attenuate the inflammatory response of human pulmonary vascular smooth muscle cells to bacterial endotoxin.
Jürgen Knobloch, Maria Feldmann, Chiara Wahl, David Jungck, Jürgen Behr

J Pharmacol Exp Ther· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory responses of airway smooth muscle cells and effects of endothelin receptor antagonism.
Jürgen Knobloch, Yingfeng Lin, Jürgen Konradi, David Jungck, Juergen Behr

Am J Respir Cell Mol Biol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages in chronic obstructive pulmonary disease.
Jürgen Knobloch, Haitham Hag, David Jungck, Katja Urban, Andrea Koch

Basic Clin Pharmacol Toxicol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-5 release of CD4+ non-effector lymphocytes is increased in COPD--modulating effects of moxifloxacin and dexamethasone.
Katharina Schild, Jürgen Knobloch, Yakup Yakin, David Jungck, Katja Urban

Int Immunopharmacol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The T-helper cell type 1 immune response to gram-negative bacterial infections is impaired in COPD.
Jürgen Knobloch, Katharina Schild, David Jungck, Katja Urban, Katja Müller

Am J Respir Crit Care Med· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apoptosis induction by thalidomide: critical for limb teratogenicity but therapeutic potential in idiopathic pulmonary fibrosis?
Jürgen Knobloch, David Jungck, Andrea Koch

Curr Mol Pharmacol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease.
Jürgen Knobloch, Bernhard Sibbing, David Jungck, Yingfeng Lin, Katja Urban

J Pharmacol Exp Ther· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis